跳至主要内容
临床试验/NCT05065762
NCT05065762已完成不适用

Patient Preference for Treatment of Moderate-To-Severe Psoriasis in Japan

Bristol-Myers Squibb1 个研究点 分布在 1 个国家目标入组 232 人开始时间: 2021年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
232
试验地点
1
主要终点
Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Height

研究概览

简要总结

The purpose of this observational study is to identify and weight the treatment attributes from the moderate-to-severe Psoriasis (PsO) patients' perspective in Japan.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Cross Sectional

入排标准

年龄范围
20 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of moderate-to-severe Psoriasis (PsO) by physician (phase 1) or self-reported (phase 2)
  • Currently taking systemic psoriasis treatment
  • Japanese resident aged 20 years and older

排除标准

  • Unable or unwilling to provide informed consent
  • Diagnosis of guttate, inverse, pustular, erythrodermic, or drug-induced psoriasis

结局指标

主要结局

Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Height

时间窗: At Baseline

Distribution of clinical characteristics of PsO participants in Phase 1: Severity of PsO

时间窗: At Baseline

Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 1: Sex

时间窗: At Baseline

Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Residence

时间窗: At Baseline

Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Weight

时间窗: At Baseline

Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Type of occupation

时间窗: At Baseline

Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Education

时间窗: At Baseline

Distribution of socio-demographic characteristics of PsO participants in Phase 1: Age

时间窗: At Baseline

Distribution of clinical characteristics of PsO participants in Phase 1: Time since PsO diagnosis

时间窗: At Baseline

Distribution of clinical characteristics of PsO participants in Phase 1: Time on current PsO treatment

时间窗: At Baseline

Distribution of socio-demographic characteristics of PsO participants in Phase 1: Level of income

时间窗: At Baseline

Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Age

时间窗: At Baseline

Distribution of clinical characteristics of PsO participants in Phase 1: Current treatments for PsO

时间窗: At Baseline

Distribution of socio-demographic characteristics of PsO participants in Phase 1: Residence

时间窗: At Baseline

Distribution of socio-demographic characteristics of PsO participants in Phase 1: Employment status

时间窗: At Baseline

Distribution of socio-demographic characteristics of PsO participants in Phase 1: Education

时间窗: At Baseline

Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Current treatments for PsO

时间窗: At Baseline

Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Previous treatments for PsO

时间窗: At Baseline

Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Comorbid conditions of interest

时间窗: At Baseline

Psoriasis (PsO) patient preferences of moderate-to-severe systemic treatment atrribute

时间窗: Within 60 minutes of survey/interview

Distribution of clinical characteristics of PsO participants in Phase 1: Total number of previous treatments

时间窗: At Baseline

Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Sex

时间窗: At Baseline

Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Time since PsO diagnosis

时间窗: At Baseline

Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Level of income

时间窗: At Baseline

Distribution of clinical characteristics of PsO participants in Phase 1: Previous treatments for PsO

时间窗: At Baseline

Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Time on current PsO treatment

时间窗: At Baseline

Distribution of socio-demographic characteristics of Psoriasis (PsO) participants in Phase 2: Employment status

时间窗: At Baseline

Distribution of clinical characteristics of Psoriasis (PsO) participants in Phase 2: Self-reported severity

时间窗: At Baseline

次要结局

未报告次要终点

研究者

发起方
Bristol-Myers Squibb
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验